Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies

Clinical trial NCT03424603 · COMPLETED

Trial details

NCT number: NCT03424603
Sponsor: Sutro Biopharma, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Lymphoma Non Hodgkin Lymphoma Multiple Myeloma Follicular Lymphoma Mantle Cell Lymphoma Diffuse Large B Cell Lymphoma Indolent Lymphoma B Cells--Tumors

Start date: 2018-02-22
Primary completion: 2024-02-15
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.